loading

Regulus Therapeutics Inc 주식(RGLS)의 최신 뉴스

pulisher
Jan 16, 2025

Regulus Therapeutics CFO sells shares worth $55,333 By Investing.com - Investing.com South Africa

Jan 16, 2025
pulisher
Jan 16, 2025

Jane Street Group LLC Takes $46,000 Position in Regulus Therapeutics Inc. (NASDAQ:RGLS) - Defense World

Jan 16, 2025
pulisher
Jan 15, 2025

Regulus Therapeutics president sells $39,721 in stock By Investing.com - Investing.com Australia

Jan 15, 2025
pulisher
Jan 15, 2025

Regulus Therapeutics CEO sells shares worth $160,494 By Investing.com - Investing.com Canada

Jan 15, 2025
pulisher
Jan 15, 2025

Regulus therapeutics executive sells shares worth $55,119 By Investing.com - Investing.com Nigeria

Jan 15, 2025
pulisher
Jan 15, 2025

Insider Selling: Regulus Therapeutics Inc. (NASDAQ:RGLS) Insider Sells 31,445 Shares of Stock - MarketBeat

Jan 15, 2025
pulisher
Jan 15, 2025

Joseph P. Hagan Sells 115,290 Shares of Regulus Therapeutics Inc. (NASDAQ:RGLS) Stock - MarketBeat

Jan 15, 2025
pulisher
Jan 15, 2025

Christopher Ray Aker Sells 38,547 Shares of Regulus Therapeutics Inc. (NASDAQ:RGLS) Stock - MarketBeat

Jan 15, 2025
pulisher
Jan 15, 2025

Regulus Therapeutics Inc. (NASDAQ:RGLS) CFO Crispina Calsada Sells 38,716 Shares - MarketBeat

Jan 15, 2025
pulisher
Jan 15, 2025

Regulus therapeutics executive sells shares worth $55,119 - Investing.com India

Jan 15, 2025
pulisher
Jan 15, 2025

Regulus Therapeutics CFO sells shares worth $55,333 - Investing.com

Jan 15, 2025
pulisher
Jan 15, 2025

Regulus Therapeutics president sells $39,721 in stock - Investing.com

Jan 15, 2025
pulisher
Jan 15, 2025

Regulus Therapeutics Inc. (NASDAQ:RGLS) Receives $10.80 Consensus PT from Analysts - Defense World

Jan 15, 2025
pulisher
Jan 12, 2025

Regulus Therapeutics Inc. (NASDAQ:RGLS) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

Jan 12, 2025
pulisher
Jan 09, 2025

Geode Capital Management LLC Lowers Stock Holdings in Regulus Therapeutics Inc. (NASDAQ:RGLS) - Defense World

Jan 09, 2025
pulisher
Jan 09, 2025

Regulus Therapeutics Inc. (NASDAQ:RGLS) Shares Acquired by Barclays PLC - Defense World

Jan 09, 2025
pulisher
Jan 02, 2025

Regulus Therapeutics Inc. (NASDAQ:RGLS) Shares Acquired by State Street Corp - Defense World

Jan 02, 2025
pulisher
Dec 31, 2024

This Biotech Wasted No Time Stealing The Premarket Show - MSN

Dec 31, 2024
pulisher
Dec 23, 2024

Regulus Therapeutics Announces Completion of Enrollment in Secon - GuruFocus.com

Dec 23, 2024
pulisher
Dec 21, 2024

Regulus Therapeutics Inc. (NASDAQ:RGLS) Receives $10.80 Average Target Price from Analysts - Defense World

Dec 21, 2024
pulisher
Dec 21, 2024

Regulus Therapeutics Announces Participation at Two Healthcare Investment Conferences - The Eastern Progress Online

Dec 21, 2024
pulisher
Dec 19, 2024

Institutional investors may overlook Regulus Therapeutics Inc.'s (NASDAQ:RGLS) recent US$12m market cap drop as long-term gains remain positive - Simply Wall St

Dec 19, 2024
pulisher
Dec 19, 2024

Fmr LLC Reduces Position in Regulus Therapeutics Inc. (NASDAQ:RGLS) - MarketBeat

Dec 19, 2024
pulisher
Dec 18, 2024

Regulus To Provide First Quarter 2017 Financial Results On May 4, 2017 - BioSpace

Dec 18, 2024
pulisher
Dec 18, 2024

Regulus Therapeutics Inc. (NASDAQ:RGLS) Receives $10.80 Average Price Target from Brokerages - MarketBeat

Dec 18, 2024
pulisher
Dec 17, 2024

The Manufacturers Life Insurance Company Purchases New Holdings in Regulus Therapeutics Inc. (NASDAQ:RGLS) - Defense World

Dec 17, 2024
pulisher
Dec 16, 2024

Regulus Therapeutics Announces First Patient Dosed in Third Cohort of Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) - StockTitan

Dec 16, 2024
pulisher
Dec 12, 2024

Regulus Therapeutics Announces Participation at Upcoming Healthcare Investment Conferences - Longview News-Journal

Dec 12, 2024
pulisher
Dec 11, 2024

Point72 Asset Management L.P. Takes $1.40 Million Position in Regulus Therapeutics Inc. (NASDAQ:RGLS) - MarketBeat

Dec 11, 2024
pulisher
Dec 08, 2024

With 64% institutional ownership, Regulus Therapeutics Inc. (NASDAQ:RGLS) is a favorite amongst the big guns - Yahoo Finance

Dec 08, 2024
pulisher
Dec 05, 2024

RA Capital Management L.P. Sells 5,483,166 Shares of Regulus Therapeutics Inc. (NASDAQ:RGLS) - MarketBeat

Dec 05, 2024
pulisher
Dec 01, 2024

NEA Management Company LLC Buys Shares of 6,467,802 Regulus Therapeutics Inc. (NASDAQ:RGLS) - MarketBeat

Dec 01, 2024
pulisher
Nov 29, 2024

Victory Capital Management Inc. Has $626,000 Holdings in Regulus Therapeutics Inc. (NASDAQ:RGLS) - Defense World

Nov 29, 2024
pulisher
Nov 26, 2024

Regulus Therapeutics Announces Participation at Upcoming Healthc - GuruFocus.com

Nov 26, 2024
pulisher
Nov 23, 2024

Brokerages Set Regulus Therapeutics Inc. (NASDAQ:RGLS) Price Target at $10.80 - MarketBeat

Nov 23, 2024
pulisher
Nov 21, 2024

Regulus Therapeutics Reports Q3 2024 Financial Results - TipRanks

Nov 21, 2024
pulisher
Nov 21, 2024

Regulus Therapeutics Reports Third Quarter 2024 Financial Results and Recent Updates - GuruFocus.com

Nov 21, 2024
pulisher
Nov 16, 2024

Annovis Bio (NYSE:ANVS) versus Regulus Therapeutics (NASDAQ:RGLS) Head-To-Head Contrast - Defense World

Nov 16, 2024
pulisher
Nov 15, 2024

RA Capital Management's Strategic Reduction in Regulus Therapeutics Holdings - GuruFocus.com

Nov 15, 2024
pulisher
Nov 15, 2024

Biotechnology Value Fund L.P. Increases Stake in Regulus Therape - GuruFocus.com

Nov 15, 2024
pulisher
Nov 15, 2024

What is HC Wainwright’s Estimate for RGLS FY2024 Earnings? - Defense World

Nov 15, 2024
pulisher
Nov 14, 2024

FY2024 Earnings Forecast for RGLS Issued By HC Wainwright - MarketBeat

Nov 14, 2024
pulisher
Nov 14, 2024

Creative Planning Makes New Investment in Regulus Therapeutics Inc. (NASDAQ:RGLS) - Defense World

Nov 14, 2024
pulisher
Nov 11, 2024

Regulus Therapeutics (NASDAQ:RGLS) Receives Buy Rating from HC Wainwright - MarketBeat

Nov 11, 2024
pulisher
Nov 07, 2024

Regulus: Q3 Earnings Snapshot - San Francisco Chronicle

Nov 07, 2024
pulisher
Nov 06, 2024

Regulus Therapeutics (RGLS) Stock Price, News & Analysis - MarketBeat

Nov 06, 2024
pulisher
Nov 05, 2024

Vanguard Group Inc's Strategic Acquisition in Regulus Therapeuti - GuruFocus.com

Nov 05, 2024
$30.75
price down icon 0.65%
$71.93
price down icon 0.75%
$19.03
price up icon 4.62%
$358.93
price down icon 2.04%
biotechnology ONC
$210.08
price up icon 2.31%
$111.93
price down icon 0.74%
자본화:     |  볼륨(24시간):